- Home
- CRGX
as 07-26-2024 4:00pm EST
Stocks
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | SAN MATEO |
| Market Cap: | 704.4M | IPO Year: | 2023 |
| Target Price: | $30.83 | AVG Volume (30 days): | 209.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.64 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.14 - $33.92 | Next Earning Date: | 08-21-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of CARGO Therapeutics Inc. (CRGX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Samsara BioCapital GP, LLC | CRGX | 10% Owner | May 30 '24 | Buy | $17.00 | 294,000 | $4,998,000.00 | 4,415,689 | SEC Form 4 |
| Third Rock Ventures V, L.P. | CRGX | 10% Owner | Nov 14 '23 | Buy | $15.00 | 1,333,333 | $19,999,995.00 | 1,807,119 | SEC Form 4 |
| Samsara BioCapital GP, LLC | CRGX | 10% Owner | Nov 14 '23 | Buy | $15.00 | 666,666 | $9,999,990.00 | 4,121,689 | SEC Form 4 |
Latest CARGO Therapeutics Inc. News
CRGX Breaking Stock News: Dive into CRGX Ticker-Specific Updates for Smart Investing
MT Newswires
4 days ago
HC Wainwright Initiates CARGO Therapeutics With Buy Rating, $33 Price Target
GlobeNewswire
16 days ago
CARGO Therapeutics Announces Phase 1 Clinical Study of Firi-cel CAR T-Cell Therapy Published in The Lancet
GlobeNewswire
2 months ago
Intermediate Capital Group plc: Notification of Transactions of Directors
ACCESSWIRE
2 months ago
Argus Research Updated Equity Report Coverage On Tego Cyber Inc.
Yahoo Finance Video
2 months ago
Lyft stock earns multiple upgrades after investor day
Engadget
2 months ago
Finally, I can make my iPhone look like total crap
Motley Fool
2 months ago
Stock Split Watch: 3 Growth Stocks That Could Be Next
GlobeNewswire
2 months ago
Intermediate Capital Group plc: Vesting in Share Awards/ Notification of Transactions of Directors
Compare CRGX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CRGX CARGO Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.